Literature DB >> 33386076

Deletions of pfhrp2 and pfhrp3 genes were uncommon in rapid diagnostic test-negative Plasmodium falciparum isolates from Uganda.

Sam L Nsobya1,2, Andrew Walakira3, Elizabeth Namirembe3, Moses Kiggundu3, Joaniter I Nankabirwa3,4, Emmanuel Ruhamyankaka3, Emmanuel Arinaitwe3, Melissa D Conrad5, Moses R Kamya3,4, Grant Dorsey5, Philip J Rosenthal5.   

Abstract

BACKGROUND: Rapid diagnostic tests (RDTs) play a key role in malaria case management. The most widely used RDT identifies Plasmodium falciparum based on immunochromatographic recognition of P. falciparum histidine-rich protein 2 (PfHRP2). Deletion of the paralogous pfhrp2 and pfhrp3 genes leads to false-negative PfHRP2-based RDTs, and has been reported in P. falciparum infections from South America and Africa. However, identification of pfhrp2/pfhrp3 deletions has usually been based only on failure to amplify these genes using PCR, without confirmation based on PfHRP2 protein expression, and understanding of the true prevalence of deletions is incomplete.
METHODS: Deletions of pfhrp2/pfhrp3 in blood samples were investigated from cross-sectional surveys in 2012-13 in three regions of varied malaria transmission intensity in Uganda. Samples with positive Giemsa-stained thick blood smears, but negative PfHRP2-based RDTs were evaluated by PCR amplification of conserved subunit ribosomal DNA for Plasmodium species, PCR amplification of pfhrp2 and pfhrp3 genes to identify deletions, and bead-based immunoassays for expression of PfHRP2.
RESULTS: Of 3516 samples collected in cross-sectional surveys, 1493 (42.5%) had positive blood smears, of which 96 (6.4%) were RDT-negative. Of these 96 RDT-negative samples, P. falciparum DNA was identified by PCR in 56 (58%) and only non-falciparum plasmodial DNA in 40 (42%). In all 56 P. falciparum-positive samples there was a failure to amplify pfhrp2 or pfhrp3: in 25 (45%) pfhrp2 was not amplified, in 39 (70%) pfhrp3 was not amplified, and in 19 (34%) neither gene was amplified. For the 39 P. falciparum-positive, RDT-negative samples available for analysis of protein expression, PfHRP2 was not identified by immunoassay in only four samples (10.3%); these four samples all had failure to amplify both pfhrp2 and pfhrp3 by PCR. Thus, only four of 96 (4.2%) smear-positive, RDT-negative samples had P. falciparum infections with deletion of pfhrp2 and pfhrp3 confirmed by failure to amplify the genes by PCR and lack of expression of PfHRP2 demonstrated by immunoassay.
CONCLUSION: False negative RDTs were uncommon. Deletions in pfhrp2 and pfhrp3 explained some of these false negatives, but most false negatives were not due to deletion of the pfhrp2 and pfhrp3 genes.

Entities:  

Keywords:  HRP2; Plasmodium falciparum; Rapid diagnostic test; pfhrp2; pfhrp3

Mesh:

Substances:

Year:  2021        PMID: 33386076      PMCID: PMC7777526          DOI: 10.1186/s12936-020-03547-4

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   2.979


  28 in total

1.  Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.

Authors:  Adithya Cattamanchi; Daniel Kyabayinze; Alan Hubbard; Philip J Rosenthal; Grant Dorsey
Journal:  Am J Trop Med Hyg       Date:  2003-02       Impact factor: 2.345

2.  Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria.

Authors:  Nelson Lee; Joanne Baker; Kathy T Andrews; Michelle L Gatton; David Bell; Qin Cheng; James McCarthy
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  Pfhrp2-Deleted Plasmodium falciparum Parasites in the Democratic Republic of the Congo: A National Cross-sectional Survey.

Authors:  Jonathan B Parr; Robert Verity; Stephanie M Doctor; Mark Janko; Kelly Carey-Ewend; Breanna J Turman; Corinna Keeler; Hannah C Slater; Amy N Whitesell; Kashamuka Mwandagalirwa; Azra C Ghani; Joris L Likwela; Antoinette K Tshefu; Michael Emch; Jonathan J Juliano; Steven R Meshnick
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

Review 4.  An Update on Malaria Rapid Diagnostic Tests.

Authors:  Avinash N Mukkala; Jason Kwan; Rachel Lau; David Harris; Dylan Kain; Andrea K Boggild
Journal:  Curr Infect Dis Rep       Date:  2018-10-23       Impact factor: 3.725

5.  Prevalence of pfhrp2 and pfhrp3 gene deletions in Puerto Lempira, Honduras.

Authors:  Joseph F Abdallah; Sheila Akinyi Okoth; Gustavo A Fontecha; Rosa Elena Mejia Torres; Engels I Banegas; María Luisa Matute; Sandra Tamara Mancero Bucheli; Ira F Goldman; Alexandre Macedo de Oliveira; John W Barnwell; Venkatachalam Udhayakumar
Journal:  Malar J       Date:  2015-01-21       Impact factor: 2.979

6.  Measures of Malaria Burden after Long-Lasting Insecticidal Net Distribution and Indoor Residual Spraying at Three Sites in Uganda: A Prospective Observational Study.

Authors:  Agaba Katureebe; Kate Zinszer; Emmanuel Arinaitwe; John Rek; Elijah Kakande; Katia Charland; Ruth Kigozi; Maxwell Kilama; Joaniter Nankabirwa; Adoke Yeka; Henry Mawejje; Arthur Mpimbaza; Henry Katamba; Martin J Donnelly; Philip J Rosenthal; Chris Drakeley; Steve W Lindsay; Sarah G Staedke; David L Smith; Bryan Greenhouse; Moses R Kamya; Grant Dorsey
Journal:  PLoS Med       Date:  2016-11-08       Impact factor: 11.069

7.  Modelling the drivers of the spread of Plasmodium falciparum hrp2 gene deletions in sub-Saharan Africa.

Authors:  Oliver J Watson; Hannah C Slater; Robert Verity; Jonathan B Parr; Melchior K Mwandagalirwa; Antoinette Tshefu; Steven R Meshnick; Azra C Ghani
Journal:  Elife       Date:  2017-08-24       Impact factor: 8.140

8.  High-throughput malaria serosurveillance using a one-step multiplex bead assay.

Authors:  Eric Rogier; Lotus van den Hoogen; Camelia Herman; Kevin Gurrala; Vena Joseph; Gillian Stresman; Jacquelin Presume; Ithamare Romilus; Gina Mondelus; Tamara Elisme; Ruth Ashton; Michelle Chang; Jean F Lemoine; Thomas Druetz; Thomas P Eisele; Alexandre Existe; Jacques Boncy; Chris Drakeley; Venkatachalam Udhayakumar
Journal:  Malar J       Date:  2019-12-04       Impact factor: 2.979

9.  Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests.

Authors:  Nathalie Wurtz; Bécaye Fall; Kim Bui; Aurélie Pascual; Mansour Fall; Cheikhou Camara; Bakary Diatta; Khadidiatou Ba Fall; Pape Saliou Mbaye; Yaya Diémé; Raymond Bercion; Boubacar Wade; Sébastien Briolant; Bruno Pradines
Journal:  Malar J       Date:  2013-01-24       Impact factor: 2.979

10.  Improving community health worker use of malaria rapid diagnostic tests in Zambia: package instructions, job aid and job aid-plus-training.

Authors:  Steven A Harvey; Larissa Jennings; Masela Chinyama; Fred Masaninga; Kurt Mulholland; David R Bell
Journal:  Malar J       Date:  2008-08-22       Impact factor: 2.979

View more
  3 in total

Review 1.  Screening strategies and laboratory assays to support Plasmodium falciparum histidine-rich protein deletion surveillance: where we are and what is needed.

Authors:  Khalid B Beshir; Jonathan B Parr; Jane Cunningham; Qin Cheng; Eric Rogier
Journal:  Malar J       Date:  2022-06-24       Impact factor: 3.469

Review 2.  Potential Opportunities and Challenges of Deploying Next Generation Sequencing and CRISPR-Cas Systems to Support Diagnostics and Surveillance Towards Malaria Control and Elimination in Africa.

Authors:  Beatus M Lyimo; Zachary R Popkin-Hall; David J Giesbrecht; Celine I Mandara; Rashid A Madebe; Catherine Bakari; Dativa Pereus; Misago D Seth; Ramadhan M Ngamba; Ruth B Mbwambo; Bronwyn MacInnis; Daniel Mbwambo; Issa Garimo; Frank Chacky; Sijenunu Aaron; Abdallah Lusasi; Fabrizio Molteni; Ritha Njau; Jane A Cunningham; Samwel Lazaro; Ally Mohamed; Jonathan J Juliano; Jeffrey A Bailey; Deus S Ishengoma
Journal:  Front Cell Infect Microbiol       Date:  2022-07-13       Impact factor: 6.073

3.  Deletion patterns, genetic variability and protein structure of pfhrp2 and pfhrp3: implications for malaria rapid diagnostic test in Amhara region, Ethiopia.

Authors:  Irene Molina-de la Fuente; Mulat Yimar; Luz García; Vicenta González; Arancha Amor; Melaku Anegagrie; Agustín Benito; Javier Martínez; Marta Moreno; Pedro Berzosa
Journal:  Malar J       Date:  2022-10-08       Impact factor: 3.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.